Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Microsoft
MSFT
5
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
ANRO Alto Neuroscience
- 2.650
- -0.040-1.49%
Close Mar 21 16:00 ET
- 2.700
- +0.050+1.89%
Post 20:01 ET
71.74MMarket Cap-1.16P/E (TTM)
2.824High2.578Low619.00KVolume2.630Open2.690Pre Close1.66MTurnover3.17%Turnover RatioLossP/E (Static)27.07MShares18.35052wk High0.47P/B51.68MFloat Cap2.57852wk Low--Dividend TTM19.50MShs Float24.000Historical High--Div YieldTTM9.12%Amplitude2.578Historical Low2.679Avg Price1Lot Size
About Alto Neuroscience Company
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.
Company Profile
SymbolANRO
Company NameAlto Neuroscience
Listing DateFeb 2, 2024
Issue Price16.00
Founded2019
CEODr. Amit Etkin, M.D.
MarketNYSE
Employees63
Fiscal Year Ends12-31
Address650 Castro Street,Suite 450
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94041
Phone1-650-200-0412
Company Executives
- Name
- Position
- Salary
- Dr. Amit Etkin, M.D.
- President, Chief Executive Officer and Chairman of the Board
- 1.86M
- Adam Savitz
- Chief Medical Officer
- 1.24M
- Michael Conick Hanley, Jr
- Chief Operating Officer
- --
- Nicholas Conrad Smith
- Chief Financial Officer and Principal Accounting Officer
- 1.60M
- Gwill York
- Independent Director
- 53.68K
- Christopher Nixon Cox
- Independent Director
- --
- Dr. Po Yu Chen
- Independent Director
- --
- Dr. Husseini Manji
- Independent Director
- --
- Mahalakshmi Radhakrishnan, M.D.
- Independent Director
- --
- Andrew Dreyfus
- Independent Director
- 107.37K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings